AI assistant
Maris Tech Ltd. — Regulatory Filings 2023
Jun 28, 2023
35043_ffr_2023-06-28_39f42da1-d364-496c-a111-9a373ea48a2d.zip
Regulatory Filings
Open in viewerOpens in your device viewer
6-K 1 ea181079-6k_maristech.htm REPORT OF FOREIGN PRIVATE ISSUER
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of June 2023 (Report No. 4)
Commission file number: 001-41260
MARIS-TECH LTD.
(Translation of registrant’s name into English)
2 Yitzhak Modai Street
Rehovot, Israel 7608804
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
CONTENTS
Results of the Annual and Special General Meeting of Shareholders
On June 28, 2023, Maris-Tech Ltd. (the “Company”) held an Annual and Special General Meeting of Shareholders (the “Meeting”) for the following purposes:
Proposal No. 1 To re-appoint Kesselman & Kesselman, a member firm of PwC International Limited as the independent auditor of the Company and to authorize the Board of Directors of the Company to determine their remuneration, until the next annual general meeting of the Company’s shareholders;
Proposal No. 2 To re-appoint Amitay Weiss and Ms. Naama Falach Avrahamy to serve as a Class II directors for a three-year term continuing until the Company’s 2026 annual general meeting of shareholders and to approve the compensation of each of Mr. Weiss and Ms. Avrahamy;
Proposal No. 3 To approve the repricing of options granted to certain of the Company’s officers and directors under the Company’s share option plan; and
Proposal No. 4 To approve the repricing of options granted to a service provider of the Company under the Company’s share option plan, who is a relative of Mr. Israel Bar, the Chief Executive Officer and a director of the Company.
At the Meeting, a quorum was present and the shareholders of the Company present or represented by proxy approved each proposal as presented at the Meeting and described in the Proxy Statement.
This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s Registration Statement on Form S-8 (File No. 333-262910 ) and Registration Statement on Form F-3 (Registration No. 333-270330 ) filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
Field: Page; Sequence: 2; Options: NewSection; Value: 1
Field: Sequence; Type: Arabic; Name: PageNo 1 Field: /Sequence
Field: /Page
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| /s/ Nir Bussy |
|---|
| Nir Bussy |
| Chief Financial Officer |
2
Field: Rule-Page
Field: /Rule-Page
.